Image_4_Pleiotropic Effect of IL-6 Produced by B-Lymphocytes During Early Phases of Adaptive Immune Responses Against TB Infection.jpeg
The role of B cells migrating to the lung and forming follicles during tuberculosis (TB) inflammation is still the subject of debate. In addition to their antibody production and antigen-presenting functions, B cells secrete different cytokines and chemokines, thus participating in complex networks of innate and adaptive immunity. Importantly, lung B-cells produce high amounts of the pleiotropic gp130 cytokine IL-6. Its role during TB infection remains controversial, partly due to the fact that IL-6 is produced by different cell types. To investigate the impact of IL-6 produced by B cells on TB susceptibility and immune responses, we established a mouse strain with specific IL-6 deficiency in B cells (CD19cre-IL-6fl/fl, B-IL-6KO) on the B6 genetic background. Selective abrogation of IL-6 in B cells resulted in shortening the lifespan of TB-infected B-IL-6KO mice compare to the wild-type controls. We provide evidence that at the initial TB stages B cells serve as a critical source of IL-6. In the lung, the effect of IL-6 deficiency in B cells is associated rather with B and T cell functioning, than with macrophage polarization. TB-infected B-IL-6KO mice displayed diminished sizes of B cells themselves, CD4+IFN-γ+, Th17+, and CD4+CXCR5+ follicular T cell populations. The pleiotropic effect of B-cell-derived IL-6 on T-cells demonstrated in our study bridges two major lymphocyte populations and sheds some light on B- and T-cells interactions during the stage of anti-TB response when the host switches on a plethora of acquired immune reactions.
History
References
- https://doi.org//10.1146/annurev.immunol.021908.132703.Cell
- https://doi.org//10.1146/annurev%E2%80%93immunol%E2%80%93032712%E2%80%93095939
- https://doi.org//10.1016/j.tube.2018.10.011
- https://doi.org//10.3389/fimmu.2012.00405
- https://doi.org//10.1016/j.smim.2014.10.005.The
- https://doi.org//10.3389/fimmu.2021.640168
- https://doi.org//10.1128/IAI.00083%E2%80%9316
- https://doi.org//10.1016/j.tube.2016.11.005
- https://doi.org//10.1134/S0006297914120098
- https://doi.org//10.1164/rccm.201707%E2%80%931475OC
- https://doi.org//10.1016/j.molimm.2019.05.004
- https://doi.org//10.1038/s41598%E2%80%93020%E2%80%9369984%E2%80%93y
- https://doi.org//10.3390/cells9122695
- https://doi.org//10.1128/iai.65.11.4843-4849.1997
- https://doi.org//10.1128/IAI.68.6.3322%E2%80%933326.2000
- https://doi.org//10.1177/000456329703400205
- https://doi.org//10.3855/jidc.10949
- https://doi.org//10.1038/srep01809
- https://doi.org//10.4049/jimmunol.171.9.4750
- https://doi.org//10.3389/fimmu.2016.00520
- https://doi.org//10.1172/JCI65728DS1
- https://doi.org//10.1016/J.BBI.2012.10.011
- https://doi.org//10.1016/j.tube.2008.05.003
- https://doi.org//10.1046/j.1365%E2%80%932249.2004.02328.x
- https://doi.org//10.1038/nature04753
- https://doi.org//10.1038/ni1449
- https://doi.org//10.1371/journal.ppat.1004099
- https://doi.org//10.3390/cells10010009
- https://doi.org//10.1086/508894
- https://doi.org//10.4049/jimmunol.178.11.7222
- https://doi.org//10.1002/path.1628
- https://doi.org//10.4049/jimmunol.173.1.68
- https://doi.org//10.1146/annurev.immunol.26.021607.090316
- https://doi.org//10.1189/jlb.0603252
- https://doi.org//10.1016/j.immuni.2009.09.002
- https://doi.org//10.1128/IAI.00196%E2%80%9306
- https://doi.org//10.1371/journal.pone.0021878
- https://doi.org//10.1016/J.BBADIS.2017.01.006
- https://doi.org//10.1371/JOURNAL.PONE.0094188
- https://doi.org//10.18632/oncotarget.24734
- https://doi.org//10.1128/IAI.02494%E2%80%9314
- https://doi.org//10.1146/annurev.immunol.021908.132532
- https://doi.org//10.3389/fmicb.2017.02008
- https://doi.org//10.1038/nrrheum.2017.83
- https://doi.org//10.1016/J.CYTO.2012.12.031
- https://doi.org//10.1371/JOURNAL.PONE.0152483
- https://doi.org//10.1371/JOURNAL.PONE.0192664
- https://doi.org//10.1016/J.EJCB.2010.10.010
- https://doi.org//10.1111/j.1365%E2%80%932249.2004.02551.x
- https://doi.org//10.1111/j.1462%E2%80%935822.2005.00612.x
- https://doi.org//10.1016/j.ajpath.2012.05.009
- https://doi.org//10.1126/SCIENCE.1176676
- https://doi.org//10.1038/icb.2012.17
- https://doi.org//10.12688/f1000research.7634.1
- https://doi.org//10.1371/journal.ppat.1005972
- https://doi.org//10.1038/ni.3153
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity